missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-23 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 1290-IL-010
388.76 EUR valid until 2024-12-16
Use promo code "21630" to get your promotional price.
This item is not returnable.
View return policy
Description
The Recombinant Human IL-23 Protein is derived from Sf 21 (baculovirus). The Recombinant Human IL-23 Protein has been validated for the following applications: Bioactivity.Specifications
Lyophilized from a 0.2μm filtered solution in MES, NaCl and EDTA with BSA as a carrier protein. | |
55.0 kDa (IL-23 single chain); 36.5 kDa (p40) & 18.5 kDa (p19) | |
10 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant |
51561 | |
IL-23 | |
Spodoptera frugiperda,Sf 21 (baculovirus)-derived human IL-23 protein, (N-terminus) Human IL-23 p40 (Ile23-Ser328) Accession &Num; P29460 GSGSSRGGSGSGGSGGGGSKL Human IL-23 p19 (Arg20-Pro189) Accession &Num; AAG37232 (C-terminus) | |
Unconjugated | |
95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |